📰 Exploratory Analysis News
Exploratory Analysis News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Exploratory Analysis. Real-time updates on events, politics, business and more.
May 23, 2024
Natera, Inc. , a global leader in cell-free DNA and genetic testing, today announced that the company, along with its collaborators, will present new data at the 2024 American Society of Clinical...
February 1, 2024
Expert oncologists in the field of breast cancer review data in HER2-positive early-stage and metastatic breast cancer.
December 16, 2023
This goddess is not among the beautiful women in mythology. It is of the science and technology (S&T) kind. It is the Good Governance through Data Science and Decision Support System (Goddess) program that funded 11 completed data science and analytics projects aimed at helping national and local government units…
December 5, 2023
SEATTLE, Dec. 05, 2023 -- Adaptive Biotechnologies Corporation , a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to...
November 13, 2023
– A Prespecified, Exploratory Analysis of Participants Reports Those with Higher Baseline Inflammation More Likely to Experience a Major Cardiovascular Event , Cardiovascular Death, and All-Cause...
November 2, 2023
First presentation of results from primary analysis of Phase 2 TRANSCEND FL study evaluating second-line treatment with Breyanzi® in relapsed or refractory follicular lymphoma demonstrate its...
January 25, 2023
The characteristics & related factors for having no vision survival following Open Globe Injury in a tertiary referral center located in a non-industrial area.
December 10, 2022
/PRNewswire/ -- New research being presented at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition focuses on a variety of approaches...
December 10, 2022
/PRNewswire/ -- New research being presented at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition focuses on a variety of approaches...
November 8, 2022
/PRNewswire/ -- UCB, a global biopharmaceutical company, today announced that it will present 15 abstracts across its rheumatology portfolio at ACR Convergence...